News
Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business.
UK drug watchdog NICE has revealed that it has recommended Eisai’s Lenvima (lenvatinib) for use on the NHS in England and Wales as a life-extending...
AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase...
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after Reuter’s revealed...
American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions.
Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry into a global...
Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has been described as an “unacceptable”...
Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by Roche and Genentech’s Herceptin (...
A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary and all secondary endpoints in patients with active psoriatic arthritis (PsA...
New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released an investigation which...
